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treated by nebulized albuterol, epinephrine, sterile saline alone. Oxygen was added 
in 2  patients.
In conclusion, after the institution of the therapeutic protocol, we noted (i) a better 
prescription, according to literature indications; (ii) a lower therapeutic choice, 
restricted to three drugs (beclomethasone, epinephrine, albuterol); (iii) a lower 
hospitalization (-20% ).
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Detection of cytomegalovirus DNA in lung tissue sections by using in situ 
polymerase chain reaction
Kun-Iing Shen, Getu Zhaori. Virology Laboratory, Beijing Children’s Hospital, 
Beijing, 100045, China
In situ polymerase chain reaction (ISPCR) is a new technique which combines the 
extremely high sensitivity of polymerase chain reaction (PCR) and the visualization 
of histopatholgical changes. The present study was undertaken to detect the cy­
tomegalovirus (CMV) DNA in formal in-fixed paraffin-embedded lung tissue. Lung 
tissue specimens from 6 infants who died of historically diagnosed cytomegalic 
inclusion disease were collected for the study. The primers allowed amplification 
o f  a 152-base CMV DNA sequence of strain AD 169 EcoRI D fragment. The 
fixed and embedded lung tissues were cut into 4-5 ¿¿m sections and were mounted 
on pre-treated slides, dewaxed, hydrated and digested with proteinase k. The 
amplification was performed on the slides in PCR reaction mixture which con­
tained 4dNTP, biotin-11-dUTP and Taq-DNA polymerase. After 10 thermocycles, 
the products amplified were visualized by streptavidin-biotin-alkaline phosphatase 
complex. The specificity of our ISPCR was established by the control specimens, 
which consisted of amplification without primer, without Taq-DNA polymerase 
and without biotin-1 IdUTP. CMV DNA positive deposits were found in several 
kinds of cells such as endothelial cells of blood vessels, epithelial cells of bronchi, 
leukocytes in the lumen of small blood vessel, the alveolar cell with or without 
inclusion bodies. A phenomenon of red blood cells ingested by macrophages 
was also noted, which demonstrated virus associated hemophagocytic syndrome 
(VAHS). Our results suggest that ISPCR technique might be of practical use in 
diagnosis and research of CMV infection.
Clinical epidemiology
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T h e  diagnosis of asthma: Main determinants for clinical decision 
E  Locatelli, G. Vertalo, E. Zanolin, M. Ferrari, I. Cerveri, R, de Marco. ECRHS; 
Cattedra di Statistica Medica, Università di Verona, Italy
811 subjects attending the European Respiratory Health Survey, stage 2, in three 
Italian centers were classified by a panel of three experienced clinicians in each 
center as current asthmatics or not. Using the “expert classification” as outcome, 
discriminant analysis and neural networks were utilized for pattern recognition of 
clinical decision, that is to determine which factors were more important for the 
physician in classifying a subject as asthmatic or not. In the first model considered, 
the variables were classified by the procedure in the following order o f importance: 
allergy to animals/plants/dust, wheezing, bronchial hyperreactivity, atopy (prick 
test and specific IgE), chest-tightness, short-breath after physical effort, woken 
by breath-shortness. The misclassification percentage of this model classification 
respect to the physician’s diagnosis was 6.7% (sensibility = 83.8%, specificity 
= 94.7%). The item “ever-asthma” , when added to the model, became the most 
relevant for asthma diagnosis and misclassification percentage decreased to 5.2% 
(sensibility = 85.7%, specificity = 96,2%). In both models, when waking by 
breath'shortness was not considered, variables order, misclassification, sensibility 
and specifity remained unchanged. In conclusion, “ever-asthma” seemed to be the 
m ost important variable for the asthma diagnosis by physicians, but it did not 
affect so much the misclassification percentage.
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Determinants of quality of life in an asthma survey
E. Van Ganse1, W, Vincken1, J.F, Boivin2, P. Bartsch3, P. Ernst2. 1Respiratory 
Division AZ VUB, Brussels, Belgium, 2Epidemiology Unit, McGill University 
Montreal, Canada, 3 Pneumology CHU Liège, Belgium
Quality of life (QOL) is a valid and useful outcome in asthma, providing infor­
mation distinct from other clinical outcomes. In a survey of asthma patients, we 
investigated the relationship between QOL and disease characteristics and therapy. 
Two groups of patients were identified: a ^cmodel> group of 51 patients super­
vised by asthma specialists and a 4CtesC§> group of 54 patients usually supervised 
by  family physicians. Patients and caregivers were questioned as to characteristics 
o f  asthma and therapy, and QOL, A predictive model for QOL was computed 
incorporating the variables linked to QOL in the model group patients.
Results: in the model group, QOL was weakly related to disease severity. De­
terminants included gender, smoking status, type of therapy, disease duration, 
depression, level of medical follow-up and socio-economic status. A model includ-
ing these variables accurately predicted QOL (adjusted R2 = 0.86). This model 
was less satisfactory for predicting QOL in the test group (adjusted R2 = 0.36). 
Conclusions: disease severity does not seem to be a strong determinant of QOL 
in asthma. The model computed in a group of well-supervised patients had only 
limited value in predicting QOL in a group of suboptimally supervised patients. 
QOL may provide useful information on actual patient’s status, especially among 
patients treated by physicians in the community, or in the absence of health care 
databases.
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Insulin and glucose levels a re  associated with impaired ventilatory function in 
non-diabetic men
D. Sparrow *, R. Lazarus2, S.T. Weiss 1. Normative Aging Study and Harvard 
Medical School, BostonM A, USA, 2 University o f Sydney, Westmead, Australia
Greater cardiovascular mortality risk among subjects with lower levels of venti­
latory function has been consistently reported from prospective studies, but the 
underlying mechanisms are not known. Increased risk of coronary heart disease is 
associated with higher serum insulin levels and is seen in insulin resistant states 
including glucose intolerance and diabetes. This study examines the relationship 
between ventilatory function and insulin values, which may contribute to the as­
sociation between ventilatory function and cardiovascular disease. Cross-sectional 
data from 1077 non-diabetic participants in the Normative Aging Study were ana­
lyzed using multiple linear regression models to control for potential confounders. 
Forced vital capacity (FVC) and Forced expiratory volume in one second (FEV j ) 
were used as measures of ventilatory function and were examined in relation 
to fasting and post-carbohydrate challenge (PC) insulin and glucose, insulin and 
glucose measures were negatively correlated with FVC and FEVj (all P < 0.001). 
Significant negative associations between ventilatory function and measures of 
insulin (all P <  0,002) and glucose (ail P <  0.02).persisted in separate multiple 
linear regression models adjusting for potential confounders including age, height, 
body mass index, waist to hip circumference ratio and smoking. In conclusion, 
negative cross-sectional associations between ventilatory function and measures 
of insulin and glucose were found in non-diabetic men. Insulin resistance and glu- 
cosc intolerance may be mechanisms contributing to the previously unexplained 
association between ventilatoiy function impairment and cardiovascular mortality. 
Mechanisms underlying the relationship between insulin, glucose and decreased 
ventilatory function are yet to be elucidated.
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Active detection of obstructive lung disease in the open population: Results 
and  economic consequences of the DIMCA programme
G. van den Boom, C,P. van Schayck, M.P.M.H. Ruttcn-van Molkcn, C. van Weei. 
Department o f General Practice and Social Medicine, University o f  Nijmegen, 
the Netherlands
Objectives: To actively detect subjects with signs and symptoms of obstruc­
tive lung disease (OLD) by means o f screening and monitoring the open adult 
population.
Design: A randomized controlled prospective study (n = 1155 experiment, n = 
535 controls).
Subjects: A random sample of the open adult population, who were not corti- 
costeroid-dependant and who were able to participate in an intensive monitoring 
study during a maximum of 5 years.
C rite ria  for detection: Three sets of criteria for detection were applied:
(a) Persistently low lung function (FEVO or increased bronchial hyperresponsive­
ness (PC2 0 and reversibility)
(b) Rapid decline in lung function with signs of bronchia! hypcrresponsiveness
(c) Moderately increased decline in lung function or signs of bronchial hyperre- 
sponsiveness.
Results: A persistently low lung function (I) was found in 7.7% of the open 
adult population. The prevalences for criteria II and III were 12.5% and 19.4% 
respectively.
Ninety-six per cent o f detected cases were undiagnosed prior to screening; the 
majority never ever visited the GP for respiratory symptoms. The total programme 
costs were Dfl. 245,800, equivalent to Dfl. 975 per detected case. Apart from 
the programme costs, active detection did not cause an increase in health care 
consumption.
Conclusion: A large part of OLD morbidity is as yet undetected. Active detection 
is able to elect untreated morbidity at reasonably low costs, First indications are 
that detected cases benefit from treatment (clinically and statistically significant).
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Relationship of blood-eosinophils to level of FEVi in  a population sample of 
adolescents and  young adults
Charlotte Suppli Ulrik. Dept, o f Cli7iical Physiology & Nuclear Medicine, 
Rigshospitalet, Copenhagen, Denmark
B ackground and Aim: In order to identify potential risk factors, other than smok­
ing, for lung function impairment, the relationship of eosinophil count, histamine 
responsiveness, skin test reactivity and respiratory symptoms to level of FEV 1 was 
studied in a population sample of 665 subjects aged 13-23 years.
M ethods; Case history was obtained by interview and questionnaire. Pulmonary 
function, blood-eosinophils, bronchial responsiveness to inhaled histamine and 
skin test reactivity to common allergens were measured using standard techniques.
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